We identified statistically significant correlations between increased FGFR2 and decreased survival probability in 5 out of 10 neuroblastoma patient datasets, although showing the opposite correlation in one additional cohort (Fig. 2 top subset). The gene discussed is FGFR2; the disease is neuroblastoma.